Infant nutritional formula with ribo-nucleotides
US5492899A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jan 10, 1994 |
| Grant date | Feb 20, 1996 |
| Priority date | — |
| Expiry date | Jan 10, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S426/801
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An improved enteral nutritional formula containing ribo-nucleotide equivalents (RNA, mono-, di- and triphosphate nucleotides, nucleosides and adjuncts such as activated sugars) at a level of at least 10 mg/100 Kcal (kilocalorie) of formula is disclosed. The formula comprises carbohydrates, lipids, proteins, vitamins and minerals and four (4) ribo-nucleotide equivalents at specific levels and ratios. The invention also discloses novel methods of production and analytical techniques. An infant formula containing cytidine nucleotide equivalents in the range of 29 to 39 mg/liter of formula, uridine nucleotide equivalents in the range of 15 to 20 mg/liter of formula, adenosine nucleotide equivalents in the range of 10 to 15 mg/liter of formula and guanosine nucleotide equivalents in the range of 14 to 20 mg/liter of formula provides a dietary formula that enhances the immune system and alleviates diarrhea.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.